Search Results

Long-Term Renal Prognosis Evaluation of Glomerulonephritis Developig After Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Vaccination.

• Authors : Ozdemir, Pınar¹; Yadigar, Serap¹ ; Ozdemir, Erman²

• Source: Southern Clinics of Istanbul Eurasia. Mar2025, Vol. 36 Issue 1, p48-56. 9p.

Record details

Bayesian spatio-temporal modeling of severe acute respiratory syndrome in Brazil: A comparative analysis across pre-, during, and post-COVID-19 eras

• Authors : Rodrigo de Souza Bulhões; Jonatha Sousa Pimentel; Paulo Canas Rodrigues

Subjects: Severe acute respiratory syndrome; Brazilian health regions; Spatio-temporal generalized linear model for areal unit data

• Source: Infect Dis ModelInfectious Disease Modelling, Vol 10, Iss 2, Pp 466-476 (2025)

Record details

Impact of Vaccination With the SCB-2019 Coronavirus Disease 2019 Vaccine on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Household Contact Study in the Philippines

• Authors : Tadesse, BT; Bravo, L; Marks, F

Subjects: Medicin och hälsovetenskap

• Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 76(7):1180-1187

Record details

Infection Dynamics of Severe Acute Respiratory Syndrome Coronavirus-2 Wild-type and Delta Variant of Concern in a Pediatric Cohort in Southern India

• Authors : Asha Jyothi Penugonda; Deepayan Biswas; Murugan Thimiri Palani

Subjects: delta; ct value; humoral immunity

• Source: Current Medical Issues, Vol 23, Iss 1, Pp 1-7 (2025)

Record details

Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203)

• Source: A Dose-escalation, Double-blinded, Randomized, Placebo-controlled Phase 1 Study to Assess the Safety, Reactogenicity, and Immunogenicity of a SARS-CoV-2 Booster Vaccine (LEM-mR203) in Healthy Adults

Record details

A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine)

• Source: A Phase 2, Randomized, Observer-blind Study to Evaluate the Safety, Reactogenicity, and Immunogenicity in Relation to the Product Attributes of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Adults

Record details

Airborne Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Hospitals: Effects of Aerosol-Generating Procedures, HEPA-Filtration Units, Patient Viral Load, and Physical Distance

• Authors : Thuresson, Sara; Fraenkel, Carl Johan; Sasinovich, Sviataslau ...

Subjects: Medical and Health Sciences; Clinical Medicine; Infectious Medicine

• Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America When the air went viral: Exploring SARS-CoV-2 in aerosols during the covid-19 pandemic.

Record details

Severe Acute Respiratory Syndrome Coronavirus 2 Variant Infection Dynamics and Pathogenesis in Transgenic K18-h ACE2 and Inbred Immunocompetent C57BL/6J Mice.

• Authors : Liu, Hongwei¹ (AUTHOR); Ramirez, Brianna M.² (AUTHOR); Wong, Talia S.^1,3 (AUTHOR)

• Source: Viruses (1999-4915). Apr2025, Vol. 17 Issue 4, p500. 29p.

Record details

The territorialization of Severe Acute Respiratory Syndrome and its socioeconomic, demographic and public health policy risk factors in Belém, state of Pará, Eastern Amazon, Brazil: a cross-sectional and ecological study.

• Authors : Gonçalves, Nelson Veiga^1,2,3,4 (AUTHOR); Leal, Alessandra Lima^1,2 (AUTHOR); Guimarães, Heloisa Maria Melo e Silva^1,2 (AUTHOR)

Subjects: *SARS disease; *DISEASE risk factors; *TYPE 2 diabetes

• Source: PLoS ONE. 3/12/2025, Vol. 20 Issue 3, p1-16. 16p.

Record details

Identification of lead small molecules for the design and development of potent severe acute respiratory syndrome coronavirus 2 main protease inhibitors.

• Authors : Awuni, Elvis¹ (AUTHOR)

• Source: Journal of Chemical Research. Mar-Apr2025, Vol. 49 Issue 2, p1-16. 16p.

Record details